Showing results (1-10 of 1,904) with videos related to
Sort By:
Pageof 191
Virologica Sinica|March 2, 2022
Updates on CRISPR-based gene editing in HIV-1/AIDS therapyZhihao Zhang, Wei Hou, Shuliang ChenJournal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan|August 23, 2007
The clustered needling, massage and cupping used for treatment of obstinate myofascitis of the back--a report of 68 casesShuliang ChenRetrovirology|June 13, 2019
CCR5 editing by Staphylococcus aureus Cas9 in human primary CD4+ T cells and hematopoietic stem/progenitor cells promotes HIV-1 resistance and CD4+ T cell enrichment in humanized miceQiaoqiao Xiao, Shuliang Chen, Qiankun Wang, et al.Scientific Reports|October 21, 2015
Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infectionPanpan Hou, Shuliang Chen, Shilei Wang, et al.Journal of Microbiology and Biotechnology|August 26, 2017
Specific Expression of Interferon-γ Induced by Synergistic Activation Mediator-Derived Systems Activates Innate Immunity and Inhibits TumorigenesisShuai Liu, Xiao Yu, Qiankun Wang, et al.Retrovirology|July 25, 2019
Correction to: CCR5 editing by Staphylococcus aureus Cas9 in human primary CD4+ T cells and hematopoietic stem/progenitor cells promotes HIV-1 resistance and CD4+ T cell enrichment in humanized miceQiaoqiao Xiao, Shuliang Chen, Qiankun Wang, et al.Frontiers in Cellular and Infection Microbiology|April 11, 2019
Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS TherapyQiaoqiao Xiao, Deyin Guo, Shuliang ChenViruses|January 17, 2018
CRISPR-Cas Targeting of Host Genes as an Antiviral StrategyShuliang Chen, Xiao Yu, Deyin GuoScientific Reports|June 7, 2018
HIV-1 inhibition in cells with CXCR4 mutant genome created by CRISPR-Cas9 and piggyBac recombinant technologiesShuai Liu, Qiankun Wang, Xiao Yu, et al.Retrovirology|November 17, 2017
Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infectionQiankun Wang, Shuliang Chen, Qiaoqiao Xiao, et al.Pageof 191